Research Note: A self-luminous light table for persons with Alzheimer's disease.
M G Figueiro1, B Plitnick1, M S Rea1
1Lighting Research Center, Rensselaer Polytechnic Institute, Troy, NY, USA.
Lighting Research & Technology (London, England : 2001)
|May 13, 2016
Summary
A novel self-luminous light table improved sleep quality and reduced agitation in Alzheimer's patients. This practical method delivers circadian-effective light, offering a new therapeutic avenue for dementia care.
Area of Science:
- Neuroscience
- Gerontology
- Chronobiology
Background:
- Alzheimer's disease and related dementias (ADRD) often disrupt sleep patterns.
- Effective light delivery is a significant challenge in treating sleep disturbances in ADRD.
- Individuals with ADRD frequently engage in table-based activities, suggesting potential for table-integrated interventions.
Purpose of the Study:
- To investigate the efficacy of a self-luminous light table as a practical method for delivering circadian-effective light to individuals with ADRD.
- To assess the impact of this intervention on sleep consolidation, efficiency, agitation, and depression.
Main Methods:
- A four-week intervention study was conducted with individuals diagnosed with ADRD.
- Participants utilized a self-luminous light table during their waking hours.
- Sleep parameters (percent and efficiency) and behavioral scores (agitation and depression) were monitored and compared to a baseline week.
Main Results:
- Significant improvements were observed in sleep percent and sleep efficiency during the four-week intervention period compared to baseline.
- A significant decrease in agitation and depression scores was noted.
- The self-luminous light table proved to be an effective and practical tool for light delivery.
Conclusions:
- Self-luminous light tables offer a viable and effective method for delivering circadian-effective light to individuals with Alzheimer's disease and related dementias.
- This intervention successfully improved sleep consolidation and reduced negative behavioral symptoms.
- The study highlights the potential of integrating light therapy into the daily routines of individuals with ADRD.
Related Concept Videos
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
01:26Alzheimer's Disease: Overview
2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K
01:30Dementia
663
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
663
01:22Photoreceptors and Visual Pathways
10.7K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
10.7K
01:14Photoluminescence: Applications
1.2K
Photoluminescence offers a wide range of applications due to its inherent sensitivity and selectivity. This technique allows for both direct and indirect analyses of the analyte. Direct quantitative analysis is possible when the analyte exhibits a favorable quantum yield for fluorescence or phosphorescence. However, an indirect analysis may be feasible if the analyte is not fluorescent or phosphorescent, or if the quantum yield is unfavorable. Indirect methods include reacting the analyte with...
1.2K